SINGAPORE: The National Cancer Centre Singapore has entered into a significant collaboration with Illumina to propel genomics research for rare cancers in the country. This strategic partnership aims to enhance the understanding and treatment of adolescent and young adult lymphoma patients within a diverse Asian cohort.
“Lymphoma in adolescents and young adults can be challenging to treat,” said Dr Jason Chan, Director of the Cancer Discovery Hub at NCCS, “As a medical oncologist, I look forward to finding new ways to more effectively target the disease to offer our young patients in Asia personalised and targeted therapies to improve survival rates and enhance their quality of life.”
Mr Zimur highlighted the importance of this research in providing a more tailored approach to lymphoma treatment in Asian populations, where current classification systems have not been extensively studied.